Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
Conditions
- Pancreatic Adenocarcinoma Resectable
Interventions
- DRUG: gemcitabine
- DRUG: Vismodegib
- PROCEDURE: Neoadjuvant chemotherapy
Sponsor
Jean-Luc Van Laethem
Collaborators